Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Time in Range and Mortality 
2. Prevalence of Liver Fibrosis in Patients With T2DM 
3. Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New- Onset T2DM 
4. Glycemic Control and Risk of Cellulitis 
5. Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction 
6. Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes 

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.

This episode is sponsored by the Overcoming Therapeutic Inertia  Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org

Presented by:

Andrew Bzowyckyj, PharmD, BDPS, CDCES, Associate Professor, Pacific University Oregon

Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Eden Miller discusses practical tips for how to effectively facilitate prior authorizations.  This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.

This episode is sponsored by the Overcoming Therapeutic Inertia  Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org

Presented by:

Eden Miller, D.O., High Lakes Health Care, Bend, OR

Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health